Shingrix vial kits
Ended Awarded
- Contract number
- SPE2DB25FGXQC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,278
Award facts
- Contract value 100% obligated
- $2,278.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $2,278.36 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster (shingles) and related complications in individuals 50 years of age and older, and this delivery order represents a critical pharmaceutical supply requirement within the federal medical procurement system.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999 and runs through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor supplying an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's contract portfolio demonstrates significant capability in fulfilling federal medical supply needs across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DB25FGXQC?
SPE2DB25FGXQC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FGXQC worth?
The government has obligated $2,278 on SPE2DB25FGXQC.
Is contract SPE2DB25FGXQC an order under another contract?
Yes. SPE2DB25FGXQC is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXQC competed?
The extent of competition for SPE2DB25FGXQC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award